“Ovarian cancer is a huge unmet need and more research in this area is critical as early diagnosis can mean the world of a difference for patient treatment,” says Inbal.

AbbVie is also trying to extend the indications for the FRα-targeting antibody-drug conjugate (ADC), with a phase 3 study on the go in platinum-sensitive ovarian cancer, and will also be tested ...

High-grade serous ovarian cancer, the most common form of the disease, is often fatal. This study investigated the genomic and immune characteristics of tumors from women who survived more than 10 ...

Ovarian cancer complications can occur when cancer spreads to other parts of the body. Often, it’s hard to know which problems are caused by treatment and which are due to advanced cancer.